ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Aesica doubles U.K. development site

by Michael McCoy
April 18, 2016 | APPEARED IN VOLUME 94, ISSUE 16

[+]Enlarge
Credit: Aesica
A view inside Aesica’s facility in Queenborough, England.
Credit: Aesica
A view inside Aesica’s facility in Queenborough, England.

With the opening of a new facility in Queenborough, England, the drug services firm Aesica Pharmaceuticals says it has doubled its drug product development capacity. Aesica says the capabilities in the new facility allow it to develop and manufacture a customer’s product from early formulation development through clinical trials and into commercialization. The Queenborough site can handle both highly potent and controlled substances, the company adds.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment